Y. Frangin
About
Y. Frangin is a scholar working on Organic Chemistry, Cellular and Molecular Neuroscience and Molecular Biology.
According to data from OpenAlex, Y. Frangin has authored 40 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 18 papers in Cellular and Molecular Neuroscience and 14 papers in Molecular Biology. Recurrent topics in Y. Frangin's work include Neuroscience and Neuropharmacology Research (17 papers), Neurotransmitter Receptor Influence on Behavior (9 papers) and Ion channel regulation and function (7 papers). Y. Frangin is often cited by papers focused on Neuroscience and Neuropharmacology Research (17 papers), Neurotransmitter Receptor Influence on Behavior (9 papers) and Ion channel regulation and function (7 papers). Y. Frangin collaborates with scholars based in France, Sweden and Belgium. Y. Frangin's co-authors include Denis Guilloteau, Patrick Emond, Sylvie Chalon, Jean‐Claude Besnard, Lucette Garreau, Moncef Bellassoued, Laurent Mauclaire, M. GAUDEMAR, Christer Halldin and Johnny Vercouillie and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Life Sciences.
In The Last Decade
Y. Frangin
38 papers receiving 509 citations
Peers
Y. Frangin
Chantal Fuseau France
Annika Rimland Sweden
Michèle Ottaviani France
Sumalee Chumpradit United States
Per Gullberg Sweden
Martine Dhilly France
Timothy Duelfer United States
Carl-Göran Stålnacke Sweden
M. Abdur Rahman United States
Kenji Furutsuka Japan
Citations per year, relative to Y. Frangin Y. Frangin (= 1×)
peers
Chantal Fuseau
Countries citing papers authored by Y. Frangin
Since
Specialization
Citations
This map shows the geographic impact of Y. Frangin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Frangin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Frangin more than expected).
Fields of papers citing papers by Y. Frangin
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Y. Frangin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Frangin. The network helps show where Y. Frangin may publish in the future.
Co-authorship network of co-authors of Y. Frangin
This figure shows the co-authorship network connecting the top 25 collaborators of Y. Frangin. A scholar is included among the top collaborators of Y. Frangin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Frangin. Y. Frangin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Mavel, Sylvie, Mohamed Abarbri, Y. Frangin, Alain Duchêne, & Patrick Emond. (2004). Fragmentation pathway of dopamine transporter ligands: N-substituted-2β-carbomethoxy-3β-phenylnortropane derivatives. Journal of Pharmaceutical and Biomedical Analysis. 35(1). 193–198.
2.
Emond, Patrick, Johnny Vercouillie, Robert B. Innis, et al.. (2002). Substituted Diphenyl Sulfides as Selective Serotonin Transporter Ligands: Synthesis and In Vitro Evaluation. Journal of Medicinal Chemistry. 45(6). 1253–1258.
3.
Emond, Patrick, Sylvie Chalon, Lucette Garreau, et al.. (2001). Synthesis of Tropane and Nortropane Analogues with Phenyl Substitutions as Serotonin Transporter Ligands. Bioorganic & Medicinal Chemistry. 9(7). 1849–1855.
4.
Vercouillie, Johnny, Patrick Emond, Johan Sandell, et al.. (2001). Carbon‐11 labelling of MADAM in two different positions: a highly selective PET radioligand for the serotonin transporter. Journal of Labelled Compounds and Radiopharmaceuticals. 44(14). 1013–1023.
5.
Loc’h, Christian, Michel Bottlaender, Patrick Emond, et al.. (1999). A selective radiobrominated cocaine analogue for imaging of dopamine uptake sites: Pharmacological evaluation and pet experiments. Life Sciences. 65(25). 2715–2726.
6.
Emond, Patrick, Johan Sandell, Christer Halldin, et al.. (1999). Synthesis and radiolabelling of 2β-carbomethoxy-3β-(3′-iodo-4′-isopropylphenyl) nortropane as a radioligand for the exploration of the serotonin transporter by SPET. Journal of Labelled Compounds and Radiopharmaceuticals. 42(4). 337–347.
7.
Sandell, Johan, Christer Halldin, Sylvie Chalon, et al.. (1999). PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter. Nuclear Medicine and Biology. 26(5). 491–499.
8.
Emond, Patrick, Christian Loc’h, Michel Bottlaender, et al.. (1999). Synthesis of (E)-N-(3-bromoprop-2-enyl)-2β-carbomethoxy-3β-(4′-tolyl) nortropane (PE2Br) and radiolabelling of [76Br]PE2Br: a potential ligand for exploration of the dopamine transporter by PET. Journal of Labelled Compounds and Radiopharmaceuticals. 42(6). 581–588.
9.
Guilloteau, Denis, Patrick Emond, Jean‐Louis Baulieu, et al.. (1998). Exploration of the Dopamine Transporter: In Vitro and In Vivo Characterization of a High-Affinity and High-Specificity Iodinated Tropane Derivative (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy- 3β-(4′-methylphenyl)nortropane (PE2I). Nuclear Medicine and Biology. 25(4). 331–337.
10.
Emond, Patrick, Sylvie Chalon, Lucette Garreau, et al.. (1997). A new iodinated tropane derivative (?-CDIT) for in vivo dopamine transporter exploration: Comparison with ?-CIT. Synapse. 26(1). 72–80.
11.
Emond, Patrick, Alain Duchêne, Sylvie Chalon, et al.. (1997). Synthesis of iodinated and radioiodinated (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy-3β-(3′,4′-dichlorophenyl) nortropane (β-CDIT): a ligand for the dopamine transporter. Journal of Labelled Compounds and Radiopharmaceuticals. 39(9). 757–772.
12.
Chalon, Sylvie, Y. Frangin, L. Pourcelot, et al.. (1996). An iodinated derivative of moclobemide as potential radioligand for brain MAO-A exploration. Life Sciences. 58(14). 1159–1169.
13.
Léna, Isabelle, Sylvie Chalon, Jean‐Louis Baulieu, et al.. (1995). Iododerivative of pargyline: A potential tracer for the exploration of monoamine oxidase sites by SPECT. Nuclear Medicine and Biology. 22(6). 727–736.
14.
Chalon, Sylvie, Y. Frangin, Lucette Garreau, et al.. (1995). Synthesis and characterization of [125I]N-(2-aminoethyl)-4-iodobenzamide as a selective monoamine oxidase B inhibitor. Nuclear Medicine and Biology. 22(5). 617–623.
15.
Chalon, Sylvie, et al.. (1993). Comparison of two radioiodinated ligands of dopamine D2 receptors in animal models: Iodobenzamide and iodoethylspiperone. Life Sciences. 52(23). 1851–1860.
16.
Foulon, Catherine, et al.. (1992). Estrogen receptor imaging with 17α-[123I]iodovinyl-11β-methoxyestradiol (MIVE2)—part I. Radiotracer preparation and characterization. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 19(3). 257–261.
17.
Foulon, Catherine, Lucette Garreau, Sylvie Chalon, et al.. (1992). Synthesis and in vitro binding properties of halogenated analogues of GBR as new dopamine uptake carrier ligands. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 19(5). 597–600.
18.
Chalon, Sylvie, et al.. (1990). Iodoethylspiperone, a new potential agent for exploration of central dopamine D2 receptors: Synthesis and preliminary in vivo study. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 17(4). 389–395.
19.
Baulieu, Jean‐Louis, F. Huguet, Sylvie Chalon, et al.. (1990). [125I]MIBG uptake and release in different regions of the rat brain. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 17(5). 511–514.
20.
Pinault, Mathieu, et al.. (1990). Total Synthesis of Siccayne. Synthesis. 1990(10). 935–937.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Chantal Fuseau Breakdown of academic impact, for papers by Annika Rimland Breakdown of academic impact, for papers by Michèle Ottaviani Breakdown of academic impact, for papers by Sumalee Chumpradit Breakdown of academic impact, for papers by Per Gullberg Breakdown of academic impact, for papers by Martine Dhilly Breakdown of academic impact, for papers by Timothy Duelfer Breakdown of academic impact, for papers by Carl-Göran Stålnacke Breakdown of academic impact, for papers by M. Abdur Rahman Breakdown of academic impact, for papers by Kenji Furutsuka